High Tower Advisors, LLC Cytokinetics Inc Transaction History

High Tower Advisors, LLC

$84.5 Billion
Q3 2025

A detailed history of High Tower Advisors, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 12,800 shares of CYTK stock, worth $850,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,800

Previous 10,423 22.81%

Holding current value

$850,432

Previous $344,000 104.36%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$33.23 - $54.96 $78,987 - $130,639	2,377 Added 22.81%	12,800 $703,000
Q2 2025 Aug 11, 2025	SELL	$29.84 - $42.92 $27,721 - $39,872	-929 Reduced 8.18%	10,423 $344,000
Q1 2025 May 12, 2025	BUY	$40.19 - $51.12 $81,545 - $103,722	2,029 Added 21.76%	11,352 $456,000
Q4 2024 Feb 07, 2025	SELL	$46.36 - $58.62 $68,659 - $86,816	-1,481 Reduced 13.71%	9,323 $438,000
Q3 2024 Nov 14, 2024	SELL	$51.22 - $60.16 $2,407 - $2,827	-47 Reduced 0.43%	10,804 $570,000

Q2 2024 Aug 13, 2024	BUY	$47.86 - $75.05 $38,144 - $59,814	797 Added 7.93%	10,851 $587,000
Q1 2024 May 06, 2024	BUY	$63.75 - $108.06 $40,545 - $68,726	636 Added 6.75%	10,054 $704,000
Q4 2023 Feb 12, 2024	BUY	$26.88 - $83.49 $14,784 - $45,919	550 Added 6.2%	9,418 $786,000
Q3 2023 Nov 08, 2023	BUY	$29.46 - $36.61 $12,785 - $15,888	434 Added 5.15%	8,868 $261,000
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $8,872 - $11,084	272 Added 3.33%	8,434 $275,000
Q4 2022 Feb 08, 2023	SELL	$35.77 - $51.11 $72,005 - $102,884	-2,013 Reduced 19.78%	8,162 $373,000
Q3 2022 Nov 09, 2022	SELL	$38.54 - $54.52 $732 - $1,035	-19 Reduced 0.19%	10,175 $494,000
Q2 2022 Aug 10, 2022	SELL	$33.93 - $48.92 $475 - $684	-14 Reduced 0.14%	10,194 $400,000
Q1 2022 May 12, 2022	BUY	$29.74 - $46.0 $3,063 - $4,738	103 Added 1.02%	10,208 $375,000
Q4 2021 Feb 10, 2022	BUY	$34.35 - $46.38 $2,541 - $3,432	74 Added 0.74%	10,105 $460,000
Q3 2021 Nov 12, 2021	BUY	$18.54 - $35.74 $574 - $1,107	31 Added 0.31%	10,031 $358,000
Q2 2021 Aug 06, 2021	SELL	$19.79 - $26.99 $39,580 - $53,980	-2,000 Reduced 16.67%	10,000 $198,000
Q1 2021 May 10, 2021	SELL	$18.57 - $25.68 $12,999 - $17,976	-700 Reduced 5.51%	12,000 $279,000
Q4 2019 Feb 14, 2020	SELL	$7.95 - $11.84 $588 - $876	-74 Reduced 0.58%	12,700 $135,000
Q2 2019 Aug 13, 2019	BUY	$7.95 - $11.25 $588 - $832	74 Added 0.58%	12,774 $143,000
Q3 2018 Nov 09, 2018	BUY	$6.4 - $9.85 $81,280 - $125,095	12,700 New	12,700 $125,000

Others Institutions Holding CYTK

# of Institutions

446

Shares Held

135M

Call Options Held

5.25M

Put Options Held

1.18M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $6.25B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Cytokinetics Inc Transaction History